Q-Line Biotec SME IPO Subscription Status
Q-Line Biotec SME IPO closed on 25 May 2026 with an overall subscription of 102.42x based on shares applied. QIB demand came in at 123.94x, NII at 146.33x, and retail at 71.44x.
Allotment will be finalised on 26 May 2026. The stock is scheduled to list on NSE and BSE on 29 May 2026.
Issue Price
Rs 343.00
GMP Today
Rs 129.00 (+37.61%)
Overall Subscription
102.42x
Issue Size
₹214.48 Cr
Allotment Date
26 May 2026
Listing Date
29 May 2026
Q-Line Biotec SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 343.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 40.75 Cr | Rs 5,050.24 Cr | 123.94x |
| FII | - | Rs 711.11 Cr | - |
| DFI | - | Rs 1,107.77 Cr | - |
| Mutual Funds | - | Rs 94.00 Cr | - |
| Other | - | Rs 3,137.37 Cr | - |
| NII | Rs 30.58 Cr | Rs 4,475.01 Cr | 146.33x |
| bNII (above Rs 10L) | Rs 20.39 Cr | Rs 3,645.72 Cr | 178.82x |
| Corporate | - | Rs 55.61 Cr | - |
| Individual | - | Rs 3,525.19 Cr | - |
| Other | - | Rs 64.92 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 10.19 Cr | Rs 829.29 Cr | 81.35x |
| Corporate | - | Rs 5.53 Cr | - |
| Individual | - | Rs 808.66 Cr | - |
| Other | - | Rs 15.11 Cr | - |
| IND | Rs 71.32 Cr | Rs 5,094.98 Cr | 71.44x |
| Total | Rs 142.65 Cr | Rs 14,620.22 Cr | 102.49x |
Q-Line Biotec SME IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 2,970 | 197 | 0.07x |
| FII | - | 36 | - |
| DFI | - | 29 | - |
| Mutual Funds | - | 3 | - |
| Other | - | 129 | - |
| NII | 743 | 49,781 | 67.00x |
| bNII (above Rs 10L) | 495 | 31,162 | 62.95x |
| Corporate | - | 357 | - |
| Individual | - | 30,416 | - |
| Other | - | 389 | - |
| sNII (Rs 2L to Rs 10L) | 248 | 18,619 | 75.08x |
| Corporate | - | 133 | - |
| Individual | - | 18,154 | - |
| Other | - | 332 | - |
| IND | 2,599 | 1,85,677 | 71.44x |
| Total | 6,312 | 2,35,655 | 37.33x |
What Do These Subscription Numbers Mean?
A subscription of 102.42x by shares means the IPO received bids for 102 times the shares reserved. Allotment odds depend on application count in each category, not share volume.
Here is what each category number tells you:
QIB at 123.94x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 123.94x, it reflects serious institutional conviction.
NII at 67.00x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 62.95x and sNII at 75.08x by applications. Share subscription was 146.33x. Allotment uses application count, not share volume.
At 71.44x subscription by applications, approximately 1 in 71 retail applicants can expect an allotment (~1% per application). Retail allotment is done by lottery when oversubscribed.
Q-Line Biotec SME IPO Allotment Chances
Allotment odds below use application subscription (number of bids received), not share or amount subscribed.
Retail (IND)
- •Application subscription: 71.44x.
- •Allotment odds: about 1 in 71 (~1% chance per application).
- •Method: Lottery. If allotted, you receive at least one lot.
- •One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.
SHNI (Rs 2 lakh to Rs 10 lakh)
- •Application subscription: 75.08x.
- •Allotment odds: about 1 in 75 for a minimum-lot application (~1% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
- •Share subscription was 81.35x. Allotment uses application count, not share volume.
BHNI (above Rs 10 lakh)
- •Application subscription: 62.95x.
- •Allotment odds: about 1 in 63 for a minimum-lot application (~2% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
- •Share subscription was 178.82x. Allotment uses application count, not share volume.
Check the Q-Line Biotec SME IPO Allotment Status page from 26 May 2026 for your allotment result.
Q-Line Biotec SME IPO GMP After Subscription
GMP for Q-Line Biotec SME stands at Rs 129.00 today, giving an estimated listing price of Rs 472.00 per share.
A subscription of 102.42x combined with a GMP of 37.61% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Q-Line Biotec SME IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Q-Line Biotec SME IPO Day-wise Subscription
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 21 May 2026 | 4.15x | 5.26x | 3.71x | 4.17x |
| Day 2 - 22 May 2026 | 5.19x | 15.62x | 10.07x | 9.87x |
| Day 3 - 25 May 2026 | 123.94x | 145.98x | 71.44x | 102.42x |
Q-Line Biotec SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 21 May 2026 |
| IPO Close Date | 25 May 2026 |
| Allotment Date | 26 May 2026 |
| Refund Initiation | 27 May 2026 |
| Share Credit to Demat | 27 May 2026 |
| Listing Date | 29 May 2026 |
| Minimum Investment | Rs 2,74,400.00 |
| Lot Size | 400 shares |
About Q-Line Biotec SME
Q-Line Biotech Limited, incorporated in 2010 (originally as POCT Services Private Limited), is an Indian diagnostics and in-vitro diagnostics (IVD) enterprise. The company is actively engaged in developing, manufacturing, and marketing a diverse range of medical reagents, consumable testing kits, point-of-care (POC) devices, and automated pathology equipment. Serving diagnostic laboratories, hospitals, and medical colleges directly and through an expansive national distributor network since 2013, its operational capabilities span fields like Clinical Chemistry, Haematology, Immunodiagnostics, and Molecular Diagnostics.
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors
High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.
IND - Individual Investors
Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.
Q-Line Biotec SME IPO Subscription FAQs
What is Q-Line Biotec SME IPO subscription status today?
Q-Line Biotec SME IPO subscription closed on 25 May 2026 with overall subscription of 102.42x (by shares) as of 17 July 2026, 2:01 AM IST. QIB 123.94x, NII 67.00x, IND 71.44x.
What is the overall subscription of Q-Line Biotec SME IPO?
Q-Line Biotec SME IPO is subscribed 102.42x overall by shares at close on 25 May 2026. QIB 123.94x, NII 67.00x, and IND 71.44x.
What is Q-Line Biotec SME IPO QIB subscription?
Q-Line Biotec SME IPO QIB (Qualified Institutional Buyers) subscription is 123.94x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Q-Line Biotec SME IPO IND subscription?
Q-Line Biotec SME IPO IND subscription is 71.44x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.
What is Q-Line Biotec SME IPO NII subscription?
Q-Line Biotec SME IPO NII (Non-Institutional Investors) subscription is 67.00x by applications. NII covers bids above Rs 2 lakh.
What are allotment chances in Q-Line Biotec SME IPO for retail?
At 71.44x subscription by applications, approximately 1 in 71 retail applicants can expect an allotment (~1% per application). Allotment is done by lottery.
When is Q-Line Biotec SME IPO allotment date?
Q-Line Biotec SME IPO allotment date is 26 May 2026. Check Q-Line Biotec SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Q-Line Biotec SME IPO subscription close?
Q-Line Biotec SME IPO subscription closed on 25 May 2026. No new applications are accepted after the close.
What is Q-Line Biotec SME IPO GMP today?
Q-Line Biotec SME IPO GMP is ₹129 today (+37.61% over issue price ₹343). See live GMP on the Q-Line Biotec SME IPO GMP Today page.
What is Q-Line Biotec SME IPO issue price and lot size?
Q-Line Biotec SME IPO issue price is ₹343 per share. Lot size is 400 shares. Minimum investment is ₹2,74,400 per lot (minimum 2 lots for SME). Issue size: ₹214.48 Cr.
When is Q-Line Biotec SME IPO listing date?
Q-Line Biotec SME IPO listing date is 29 May 2026 on NSE and BSE. Allotment is on 26 May 2026.
How does subscription affect Q-Line Biotec SME IPO allotment?
Allotment odds in Q-Line Biotec SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII proportional allotment at 67.00x by applications means roughly 1 in 67 for minimum-lot bids; bNII at 62.95x (~1 in 63). At 102.42x overall, competition is very high.
For allotment results from 26 May 2026, visit the Q-Line Biotec SME IPO Allotment Status page. For listing day updates on 29 May 2026, download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Subscription data verified before publish.